| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 829,963 | 1,030,467 | 1,026,856 | | Cost of Revenue | 738,343 | 744,477 | 633,174 | | | Gross Profit | 91,620 | 285,990 | 393,682 | | | Operating Expenses | | Research Development | 109,201 | 128,869 | 97,105 | | Selling General and Administrative | 239,067 | 245,189 | 218,371 | | Non Recurring | 131,065 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (387,713) | (88,068) | 78,206 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 483 | 15,433 | 12,822 | | Earnings Before Interest And Taxes | (387,230) | (72,635) | 91,028 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (387,230) | (72,635) | 91,028 | | Income Tax Expense | 46,226 | (35,785) | 26,206 | | Minority Interest | 302 |
-
| 136 | | | | Net Income From Continuing Ops | (433,154) | (36,850) | 64,958 | | | Non-recurring Events | | Discontinued Operations | 2,042 | 1,513 | 3,080 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (431,112) | (35,337) | 68,038 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($431,112) | ($35,337) | $68,038 |
|
1.48% Nasdaq 
Income Statement
